February 28, 2018

Award Announced in Partnership with Chordoma Foundation

 

The Mark Foundation has partnered with the Chordoma Foundation to sponsor a Therapeutic Innovation Award aimed at accelerating the development of drug therapies targeting brachyury, a transcription factor that plays a key role in chordoma and other cancers.

The recipient of this one-year award totaling $150,000 will be announced in the fall of 2018.